top button
    Got Questions


Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore



    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

Polymerase Chain Reaction Consumables Market Forecast : Pin-Point Analysis for Changing Competitive Dynamics

0 votes
5 views

Transparency Market Research (TMR) has published a new report titled, Polymerase Chain Reaction (PCR) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” According to the report, the global PCR market is projected to reach over US$ 7.0 Bn by 2026 expanding at a considerable CAGR from 2018 to 2026. North America is expected to dominate the global PCR market during the forecast period, due to high adoption of technologically advanced molecular diagnostic products, growing incidence of infectious diseases, rising prevalence of various types of cancer, growing trend of self-diagnosis of diseases, and affordability of high-cost testing processes for people in the region.

Reagents Segment to Dominate the Global PCR Market

The report offers detailed segmentation of the global PCR market based on product and end-user. In terms of product, the market has been segmented into instruments, reagents, and consumables. The reagents segment held the leading market share in the year 2017 and is expected to expand at the highest CAGR during the forecast period. This is attributable to high consumption of reagents for the PCR technique. Introduction of advanced reagents specific to the type of test is expected to boost the global demand for PCR reagents in the near future. PCR reagents include template DNA, PCR primers and probes, dNTPs, PCR buffers, enzymes, and master mixes. PCR consumables mostly include PCR tubes, plates, and other accessories required to conduct PCR reactions. The instruments segment has been sub-categorized into standard PCR systems, RT PCR systems, and digital PCR systems. Among these, the digital PCR systems sub-segment is expected to witness growth at a significantly rapid pace during the forecast period. This is attributable to advantages of digital PCR systems such as precision, sensitivity, accuracy, reproducibility, direct quantification and multiplexing, and speed of the analysis.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830

Pharmaceutical & Biotechnology Industry Segment Held a Major Share of the Global PCR Market in 2017

The PCR technique has been found to be useful in pharmaceutical and biotechnology research activities as well as microbial quality testing. The technique is also applied in genetic engineering. Genetic engineering is the key driver for the global PCR market. It is used to identify genes related to certain phenotypes including genetic disorders. Regular testing of the microbial load of raw materials and finished products is an important process in the pharmaceutical & biotechnology industry. Sophisticated analytical methods such as polymerase chain reaction (PCR) have been widely applied for quality control analysis in the pharmaceutical sector.

Market in Asia Pacific to Expand at a High CAGR

Molecular diagnosis has revolutionized the modern diagnosis technology. PCR has become a method of choice in early and accurate detection of diseases. Expansion by leading manufacturers of PCR products in the Asia Pacific region by strengthening of the distribution network and new product launches in developing countries of Asia Pacific are key factors likely to drive the PCR market in the region during the forecast period. Moreover, rise in the incidence of cancer and infectious diseases has resulted in increase in the demand for use of the PCR technique in clinical diagnosis of these diseases in Asia Pacific. For instance, according to the Korea Central Cancer Registry published in 2016, there were 217,057 cancer cases in South Korea in 2014. Moreover, in 2016, the WHO estimated that the Asia Pacific region has the second-highest number (i.e. 5.1 million) of people living with HIV across the world. Thus, Asia Pacific is expected to be the most lucrative market for PCR by 2026.

Competition Landscape

Major players operating in the global PCR market are Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies. Key players are expanding their product portfolio through mergers and acquisitions and partnerships and collaborations with leading pharmaceutical and biotechnology companies and by offering technologically advanced products.

More Trending Reports by Transparency Market Research –

Shock Wave Therapy Device Market: prnewswire.com/news-releases/shock-wave-therapy-device-market-to-reach-us-1399-mn-by-2025-orthopedic-and-urology-application-leads-the-market-677627753.html

Life Sciences BPO Market: prnewswire.com/news-releases/life-sciences-bpo-market-is-expected-to-touch-us286-3-billion-by-2023—says-tmr-300813081.html

posted Feb 12 by Bella Watson

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

Transparency Market Research (TMR) has published a new report titled, “Polymerase Chain Reaction (PCR) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” According to the report, the global PCR market is projected to reach over US$ 7.0 Bn by 2026 expanding at a considerable CAGR from 2018 to 2026. North America is expected to dominate the global PCR market during the forecast period, due to high adoption of technologically advanced molecular diagnostic products, growing incidence of infectious diseases, rising prevalence of various types of cancer, growing trend of self-diagnosis of diseases, and affordability of high-cost testing processes for people in the region.

Reagents Segment to Dominate the Global PCR Market

The report offers detailed segmentation of the global PCR market based on product and end-user. In terms of product, the market has been segmented into instruments, reagents, and consumables. The reagents segment held the leading market share in the year 2017 and is expected to expand at the highest CAGR during the forecast period. This is attributable to high consumption of reagents for the PCR technique. Introduction of advanced reagents specific to the type of test is expected to boost the global demand for PCR reagents in the near future. PCR reagents include template DNA, PCR primers and probes, dNTPs, PCR buffers, enzymes, and master mixes.

PCR consumables mostly include PCR tubes, plates, and other accessories required to conduct PCR reactions. The instruments segment has been sub-categorized into standard PCR systems, RT PCR systems, and digital PCR systems. Among these, the digital PCR systems sub-segment is expected to witness growth at a significantly rapid pace during the forecast period. This is attributable to advantages of digital PCR systems such as precision, sensitivity, accuracy, reproducibility, direct quantification and multiplexing, and speed of the analysis.

Request PDF Sample of Polymerase Chain Reaction Consumables Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830

Pharmaceutical & Biotechnology Industry Segment Held a Major Share of the Global PCR Market in 2017

The PCR technique has been found to be useful in pharmaceutical and biotechnology research activities as well as microbial quality testing. The technique is also applied in genetic engineering. Genetic engineering is the key driver for the global PCR market. It is used to identify genes related to certain phenotypes including genetic disorders. Regular testing of the microbial load of raw materials and finished products is an important process in the pharmaceutical & biotechnology industry. Sophisticated analytical methods such as polymerase chain reaction (PCR) have been widely applied for quality control analysis in the pharmaceutical sector.

Market in Asia Pacific to Expand at a High CAGR

Molecular diagnosis has revolutionized the modern diagnosis technology. PCR has become a method of choice in early and accurate detection of diseases. Expansion by leading manufacturers of PCR products in the Asia Pacific region by strengthening of the distribution network and new product launches in developing countries of Asia Pacific are key factors likely to drive the PCR market in the region during the forecast period.

Moreover, rise in the incidence of cancer and infectious diseases has resulted in increase in the demand for use of the PCR technique in clinical diagnosis of these diseases in Asia Pacific. For instance, according to the Korea Central Cancer Registry published in 2016, there were 217,057 cancer cases in South Korea in 2014. Moreover, in 2016, the WHO estimated that the Asia Pacific region has the second-highest number (i.e. 5.1 million) of people living with HIV across the world. Thus, Asia Pacific is expected to be the most lucrative market for PCR by 2026.

Buy Now “Polymerase Chain Reaction Consumables Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=830&ltype=S

Competition Landscape

Major players operating in the global PCR market are Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies. Key players are expanding their product portfolio through mergers and acquisitions and partnerships and collaborations with leading pharmaceutical and biotechnology companies and by offering technologically advanced products.

More Trending Reports by Transparency Market Research –

Erectile Dysfunction Drugs Market: prnewswire.com/news-releases/erectile-dysfunction-drugs-market-is-expected-to-reach-usd-34-billion-globally-in-2019-transparency-market-research-228593931.html

Veterinary Drugs Market: prnewswire.com/news-releases/veterinary-drugs-market-to-reach-us267-bn-by-2024-rising-inclination-toward-ensuring-health-and-wellness-of-companion-animals-to-aid-growth-says-tmr-615866193.html

0 votes

Global Pharmacy Automation Systems Market – Overview

Growing incidences of injuries as well as deaths because of the mistakes in the medical prescriptions are putting a constant pressure on the overall healthcare sector. Both the healthcare service providers as well as the pharmacists are looking out for more effective and accurate technologies to prevent such recurring medical mishaps. In addition to this, the medication distribution system is turning more complex each passing day with the growing number of patients, visitors, and their respective safety needs.

Report overview @ https://www.transparencymarketresearch.com/pharmacy-automation-systems.html

Advanced technologies such as pharmacy automation systems are now coming up as the most efficient tools to tackle this serious problem. The objective of these tools is to reduce the errors in medical prescriptions and optimize patient safety. Installation of such pharmacy automation systems is thus helping healthcare service providers and pharmacists to cut down their losses and scale up efficiency and productivity.

Global Pharmacy Automation Systems Market – Notable Developments

Some of the leading companies in the global pharmacy automation systems market include names such as Parata System Inc., Kirby Lester, McKesson Corp, and Omnicell Inc. among others. These leading players in the market are concentrating on product development and innovation to build their brand name and generate more revenue.

Some of the recent notable developments in the global pharmacy automation systems market are given below:

  • In 2016, Omnicell announced that the company has launched SureMed software by Omnicell Guided Packing. This software was developed with an objective to improve the accuracy of the pharmacists’ in filling numerous SureMed medication blister cards.
  • In 2016, BD announced a launch of a new software for Pyxis ES System. The new product will ensure safety of patient and also ensure the workflow benefits for health systems’ medication management.

Get Sample with Latest Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=815

Global Pharmacy Automation Systems Market – Drivers and Restraints

The growth of the pharmacy automation systems market is primarily driven by the fact that there have been initiatives to improve the reimbursement policies and stricter governmental regulation policies. With mandates in place about the dosage, prescription labeling, and packaging among others, the use of pharmacy automated systems is helping to scale up the productivity of the pharmacies.

Another important factor that has been pushing the growth of the global pharmacy automation systems market is increasing pressure on the healthcare service providers to cut down the medication errors. Moreover, there has been a substantial rise in terms of number of patients across the globe who need prescription drugs. This coupled with growing healthcare expenditure has significantly highlighted the importance of using pharmacy automation systems. Naturally, the growth of the market is moving in the right direction.

Global Pharmacy Automation Systems Market – Geographical Outlook

From a geographical point of view, the global pharmacy automation systems market is primarily divided into five main regions viz. North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Of these mentioned segments, the global pharmacy automation systems is currently dominated by the regional segment of North America. A developed healthcare infrastructure coupled with increasing pressure to cut down the medication errors is prompting higher adoption of these pharmacy automation systems. In addition to this, the government too is putting down strict regulations about the distribution prescription medicines. This too is expected to help the development of the pharmacy automation systems market in the North America region.

On the other hand, the regional segment of Asia Pacific is expected to show a promising growth in the coming years of the forecast period. The region is home to some of the fastest growing economies in the world in China and India. Both the nations are spending heavily on the development and improvement of their domestic healthcare infrastructure. This is expected to give a solid impetus to the development of pharmacy automation systems market in the Asia Pacific region.

More Trending Reports by Transparency Market Research –

ePharmacy Market: prnewswire.com/news-releases/epharmacy-market-to-reach-us128-billion-by-2023-transparency-market-research-560938961.html

Canada Home Healthcare Market: prnewswire.com/news-releases/canada-home-healthcare-market-set-to-reach-us1894-bn-by-the-end-of-2020-transparency-market-research-565741581.html

0 votes

A report published by Transparency Market Research (TMR) sheds light on the key dynamics of the global market for bone densitometers and provides a basis to understand its competitive landscape. The global bone densitometers market has opened its doors to the entry of new and emerging players, and this has resulted in a highly fragmented arrangement of market vendors. It is expected that the established vendors in the global market for bone densitometers would respond to the influx of newbie vendors by making greater investments in marketing and promotions. Despite the presence of a large number of large, small, and medium-sized players, the position of the leading market players in projected to remain unmoved over the coming years.

The vendors that have existed in the market for over a decade are expected to concentrate on expanding their geographical reach in the forthcoming years. Furthermore, improvement in the quality of the densitometers is also a key strategy that is currently on the minds of the market players. Some of the key players in the global market for bone densitometers are Hitachi, Ltd., GE Healthcare, Beammed, Osteometer Meditech Inc., and Lone Oak Medical Technologies LLC.

Request PDF Sample of Bone Densitometers Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1643

The global market for bone densitometers was valued at US$0.84 bn in 2015 and is expected to escalate to a value of US$1.11 bn by the end of 2024. The CAGR of the global market for bone densitometers over the period between 2016 and 2024 is estimated to be 3.10%. Based on end-use, the global market for bone densitometers has reaped the highest revenues through hospitals. Geographically, the immaculate disposition of the healthcare industry in North America has facilitated growth of the regional market.

Increasing Incidence of Osteoporosis to Propel Demand

Bone densitometers are used to measure the density of bones by means of an X-ray, and is used in the detection of diseases such osteoporosis or osteopenia. Low boen density is a sign of weak bones, and it is extremely essential to treat such a condition to avoid fractures or bone dislodgements. In recent times, the incidence of osteoporosis has risen due to the changing lifestyles and eating habits of the masses This has given an impetus to the growth of the global market for bone densitometers.

Enquiry for Discount on “Bone Densitometers Market” Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1643

Furthermore, the developments in the healthcare infrastructure of all the key regions across the globe have also given an impetus to the growth of the global market for bone densitometers. The geriatric population across the globe has been rising at a healthy rate, and this has furthered the demand for bone densitometers across the globe.

Sluggish Manufacturing of Bone Densitometers to Restrain Growth

Although the demand for bone densitometers has flown in from several regional longitudes, the manufacturers have failed to cater to this demand over the past decade. This has emerged as a major roadblock for the global market for bone densitometers because a major chunk of revenues that could have been generated is lost to sluggish manufacturing. Nevertheless, the gradual developments in the manufacturing standards of vendors are expected to bode well for the global bone densitometers market.

More Trending Reports by Transparency Market Research –

Gout Therapeutic Market: globenewswire.com/news-release/2019/06/03/1863351/0/en/Gout-Therapeutic-Market-is-projected-to-reach-US-3820-Million-by-2027-TMR.html

Heparin Market: globenewswire.com/news-release/2017/11/08/1177610/0/en/Heparin-Market-to-Reach-a-Valuation-of-US-16-3-Billion-by-the-End-of-2025-Transparency-Market-Research.html

0 votes

Tools and instruments that are available in the clinical microbiology labs for analysis of patient samples and diagnosis are evolving continuously. The main impetus behind this is to reduce the overall time taken to secure results from those lab instruments. In addition to that, increasing the sample turn-around time with the ultimate goal of earlier patient treatment, enhancing the ease of sample processing, and better recovery rates are also comprise the purpose for such evolution. This is particularly true in the case of Antimicrobial Susceptibility Test (AST). It is every hour saved in getting the results lead to an earlier switch to targeted antibiotic therapy that will have a direct influence on the improvement of clinical outcomes.

Global antimicrobial susceptibility test market is likely to observe a surge in its demand owing to overuse of antibiotics in medicine, antibiotic resistance mechanisms has come up as threat to modern medicine by reducing the utility of clinically relevant antibiotics.

Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., HiMedia Laboratories, Biotron Healthcare, Beckman Coulter, and Creative Diagnostics are some of the leading names that operate in the global antimicrobial susceptibility test market.

Request PDF Sample of Antimicrobial Susceptibility Test Market Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=31508

According to a new study by Transparency Market Research (TMR), it is predicted that the global antimicrobial susceptibility test market will expand at a growth rate of 4.6% CAGR between 2017 and 2025. Global antimicrobial susceptibility test market is estimated to reach US$ 3814.0 mn by the end of the forecast period that spans from 2017 to 2025.

Increased Government Initiatives to Prevent Antibiotic Resistance Fuels North American Market

North America is expected to be the retain the position of the most promising market in the global antimicrobial susceptibility test market owing to the emergence of a multidrug resistant strain of Salmonella in the US. For example, in accordance with the report by Centers for Disease Control and Prevention (CDC), around 2 million people in the US were infected with antibiotic-resistant bacteria annually and 23,000 people died as a result of such infection.

Furthermore, government agencies in the US have taken the onus to control and prevent antibiotic resistance, which is anticipated to accelerate the adoption of antimicrobial susceptibility test in the country.

Enquiry for Discount on “Antimicrobial Susceptibility Test Market” Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=31508

Antimicrobial susceptibility test market in Asia Pacific is estimated to witness substantial growth during the period of forecast, 2017 to 2025. The market is expected to thrive on increased prevalence of microbial infections and rising consumption of antibiotics that eventually leads to development of resistance amongst the people. According to a report by WHO prevalence of multidrug –resistant tuberculosis is quite high though the treatment is very limited. Such factors trigger the growth of antimicrobial susceptibility test market in the region.

Improved Knowledge of Molecular Mechanisms Needed to Control Multidrug Resistance 

In the recent years, there has been a drastic rise in the antibiotic resistance amongst bacterial pathogens and this is regarded as one of the biggest threats to global health in the current era. Globally, antibiotic resistance leads to 700,000 deaths each year and medical experts estimate the number could grow to 10 million deaths per year by 2050. Unless stringent actions are taken to check the misuse and overuse of antibiotics, antibiotic resistance will wreak havoc worldwide.

Data also hint that, though antibiotic resistant bacterial infections can occur in the community but most deaths owing to resistance take place in various in-patient healthcare settings such as nursing homes and hospitals. In a hospital setting, when a patient displays signs of infection such as sepsis, they are quickly put on empiric broad spectrum antibiotics. Current literature suggests that around 51% of the patients in general wards and nearly 82% of the patients in Intensive Care Units (ICUs) are already on antibiotics within 4 hours prior to collection of blood samples for culture.

Government healthcare regulatory agencies are proactively implementing measures essential to reduce or control its prevalence. In July 2018, the UK Standards for Microbiology Investigation (UK SMIs) made a recommendation of a core set of antibiotic susceptibilities, which should be set up for a variety of bacterial species isolated from various types of specimen.

Besides, enhanced knowledge of molecular mechanisms that control multidrug resistance is forecasted to facilitate the development of novel therapies, which would combat intractable infections and assist in the cultivation of a deeper understanding of the pathobiology of microbial organisms. Several awareness programs are being conducted to facilitate proper usage of new drugs to re-establish dominance over diseases.

0 votes

Treatment-resistant Depression Market: Introduction

  • Depression is feeling of sadness that interferes with functioning and/or a decreased interest or pleasure in activities. It has a number of side effects, such as change in hormonal levels and emotionally distressing events, and hereditary and side effects of drugs lead to depression. Antidepressants, electroconvulsive therapy, and psychotherapy may help to treat the patient suffering from depression.
  • Treatment-resistant depression is a disorder where the patient does not respond to antidepressants used to treat the condition. The effect of antidepressants is observed to be minimal or nil in case of treatment-resistant depression.
  • Expansion of the treatment-resistant depression market is anticipated to be driven by increase in demand for new therapies for treatment-resistant depression, promising products in pipeline, and approved drugs by the Food and Drug Administration (FDA)

Report Overview @ https://www.transparencymarketresearch.com/treatment-resistant-depression-market.html

Key Drivers of Global Treatment-resistant Depression Market

  • NMDA receptor antagonists and combination drugs developed by Janssen Pharmaceuticals, Inc. (Johnson & Johnson Services, Inc.) and Eli Lilly and Company, respectively, are available to treat drug-resistant depression. These medications are available in the form of nasal sprays and tablets.
  • Prominent market players have entered into agreement for the development of new therapeutics in neurological disorders. In March 2019, Janssen Pharmaceuticals, Inc. (Johnson & Johnson Services, Inc.) received the FDA approval for SPRAVATO (esketamine) CIII, a nasal spray used in combination with an oral antidepressant in adults with treatment-resistant depression. Evotec AG entered into a license agreement with Janssen Pharmaceuticals, Inc. regarding its NR2B subtype selective NMDA-antagonist portfolio indicated for depression disorders. As per the agreement, Janssen Pharmaceuticals, Inc. was granted worldwide license to a series of small molecule drug candidates, develop the compounds, and market the products.
  • In September 2019, Evotec AG and F. Hoffmann-La Roche Ltd entered into an agreement for Phase II clinical development of EVT 101 indicated for treatment-resistant depression

To Know the Scope of Our Report Get a Brochure on “Treatment-resistant Depression Market” here @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=72852

North America to Hold a Major Share of Global Treatment-resistant Depression Market

  • Globally, North America is likely to hold the maximum market share due to extensive research and development activities, new product approvals, and increase in prevalence of treatment-resistant depression
  • Sage Therapeutics is developing SAGE-217 for treatment-resistant depression and generalized anxiety disorder. The company is evaluating SAGE-217 as the next-generation positive allosteric modulator (PAM) of GABAA receptors under Phase III for the treatment of treatment-resistant depression and generalized anxiety disorder.
  • Navitor Pharmaceuticals, Inc. is developing a drug NV-5138 for the treatment of treatment-resistant depression. NV-5138 is orally active small molecule that selectively activates mTORC1 in the brain, which is expected to have a potential to treat cognitive impairment, depression, and other neurological conditions.
  • Research centers and government agencies are also conducting research on neurological disorder treatment. The National Institute of Mental Health funded a research on Rapidly-Acting Treatments for Treatment-Resistant Depression (RAPID). The research focuses on identifying and analyzing pharmacological and non-pharmacological treatments for various types of depression.

Pre Book “Treatment-resistant Depression Market” Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=72852&ltype=S

Key Players Operating in Global Market:

Major players operating in the global treatment-resistant depression market are:

  • Janssen Pharmaceuticals, Inc. (Johnson & Johnson Services, Inc.)
  • Eli Lilly and Company
...